ID29046A - Asam 2,3,4,5-tetrahidro-1h-(1,4)benzodiazepin-3-hidroksamat sebagai matriks penghambat metaloproteinase - Google Patents

Asam 2,3,4,5-tetrahidro-1h-(1,4)benzodiazepin-3-hidroksamat sebagai matriks penghambat metaloproteinase

Info

Publication number: ID29046A
Authority: ID; Indonesia
Prior art keywords: hydroxycate; tetrahidro; metaloproteinase; hazing; benzodiazepin
Prior art date: 1999-01-27

Application number

IDW00200101465A

Other languages

English (en)

Inventor

J D Albert

E G Delossantos

J I Levin

J M Chen

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-27

Filing date

2000-01-27

Publication date

2001-07-26

2000-01-27 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

2001-07-26 Publication of ID29046A publication Critical patent/ID29046A/id

Links

239000002253 acid Substances 0.000 title 1
239000011159 matrix material Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Virology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Cardiology (AREA)

IDW00200101465A 1999-01-27 2000-01-27 Asam 2,3,4,5-tetrahidro-1h-(1,4)benzodiazepin-3-hidroksamat sebagai matriks penghambat metaloproteinase ID29046A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US23908099A	1999-01-27	1999-01-27

Publications (1)

Publication Number	Publication Date
ID29046A true ID29046A (id)	2001-07-26

Family

ID=22900512

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101465A ID29046A (id)	1999-01-27	2000-01-27	Asam 2,3,4,5-tetrahidro-1h-(1,4)benzodiazepin-3-hidroksamat sebagai matriks penghambat metaloproteinase

Country Status (25)

Country	Link
EP (1)	EP1147095B1 (id)
JP (1)	JP2002535392A (id)
KR (1)	KR20010101730A (id)
CN (1)	CN1197849C (id)
AR (1)	AR022423A1 (id)
AT (1)	ATE273288T1 (id)
AU (1)	AU767039B2 (id)
BG (1)	BG105736A (id)
BR (1)	BR0007759A (id)
CA (1)	CA2356267A1 (id)
CZ (1)	CZ20012637A3 (id)
DE (1)	DE60012883T2 (id)
EA (1)	EA200100809A1 (id)
ES (1)	ES2223470T3 (id)
HU (1)	HUP0105302A3 (id)
ID (1)	ID29046A (id)
IL (1)	IL144168A0 (id)
NO (1)	NO20013675L (id)
NZ (1)	NZ511885A (id)
PL (1)	PL349025A1 (id)
PT (1)	PT1147095E (id)
SK (1)	SK10422001A3 (id)
TR (1)	TR200102131T2 (id)
WO (1)	WO2000044730A1 (id)
ZA (1)	ZA200104321B (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2357110A1 (en) *	2001-04-11	2002-10-11	American Cyanamid Company	Method for the treatment of polycystic kidney disease
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
WO2003016248A2 (en)	2001-08-17	2003-02-27	Bristol-Myers Squibb Company Patent Department	Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
MXPA04004010A (es)	2001-11-01	2004-07-23	Wyeth Corp	Acidos hidroxamicos de aril sulfonamida alenicos como inhibidores de tace y metaloproteinasa de matriz.
PE20030701A1 (es)	2001-12-20	2003-08-21	Schering Corp	Compuestos para el tratamiento de trastornos inflamatorios
US7488754B2 (en)	2002-04-05	2009-02-10	Wyeth	Method for the treatment of polycystic kidney disease
EP1537098A1 (en)	2002-08-13	2005-06-08	Warner-Lambert Company LLC	Monocyclic derivatives as matrix metalloproteinase inhibitors
US7199155B2 (en)	2002-12-23	2007-04-03	Wyeth Holdings Corporation	Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
ATE510174T1 (de)	2003-05-21	2011-06-15	Alexza Pharmaceuticals Inc	Schlag gezündete unabhängige heizeinheit
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
ES2349940T3 (es) *	2004-07-21	2011-01-13	Merck Serono Sa	DERIVADOS DE OCTAHIDROPIRROLO[2,3,c]PIRIDINA Y USO FARMACÉUTICO DE LOS MISMOS.
AU2004322756B2 (en)	2004-08-12	2011-04-14	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
EP1865001A1 (en) *	2006-06-08	2007-12-12	Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh	Specific protease inhibitors and their use in cancer therapy
US20100226922A1 (en) *	2006-06-08	2010-09-09	Dorothea Maetzel	Specific protease inhibitors and their use in cancer therapy
US20080216828A1 (en)	2007-03-09	2008-09-11	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
FR2950056B1 (fr)	2009-09-17	2011-08-26	Galderma Res & Dev	Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
FR2950057B1 (fr)	2009-09-17	2011-08-26	Galderma Res & Dev	Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
PT2597084T (pt)	2010-07-08	2016-08-12	Kaken Pharma Co Ltd	Derivado de n-hidroxiformamida e medicamento contendo o mesmo
SG188545A1 (en) *	2010-09-17	2013-04-30	Univ Tokyo	Composition for maintaining function of platelets
US12214118B2 (en)	2018-02-02	2025-02-04	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device
AU2019352741A1 (en)	2018-10-04	2021-05-06	Assistance Publique-Hôpitaux De Paris (Aphp)	EGFR inhibitors for treating keratodermas
EP4031160A4 (en) *	2019-09-19	2023-10-11	New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special Surgery	STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5455258A (en) *	1993-01-06	1995-10-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
DK0821671T3 (da) *	1995-04-20	2001-04-23	Pfizer	Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
KR100475206B1 (ko) *	1995-11-13	2005-12-16	훽스트 악티엔게젤샤프트	사이클릭및헤테로사이클릭N-치환된α-이미노하이드록삼산및카복실산
US5753653A (en) *	1995-12-08	1998-05-19	Agouron Pharmaceuticals, Inc.	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
ES2233275T3 (es) *	1995-12-08	2005-06-16	Agouron Pharmaceuticals, Inc.	Intermediarios que sirven para la preparacion de inhibidores de metaloproteinasas.
ATE226573T1 (de) *	1996-08-28	2002-11-15	Procter & Gamble	Heterozyklische metalloproteaseinhibitoren
CZ62799A3 (cs) *	1996-08-28	1999-07-14	The Procter & Gamble Company	Heterocyklické metaloproteázové inhibitory
DK0927168T3 (da) *	1996-08-28	2003-03-10	Procter & Gamble	1,3-diheterocykliske metalloproteaseinhibitorer
IL137162A0 (en) *	1998-01-27	2001-07-24	American Cyanamid Co	2,3,4,5-tetrahydro -1h- [1,4]-benzodiazepine -3- hydroxamic acids as matrix metalloproteinase inhibitors

2000
- 2000-01-26 AR ARP000100323A patent/AR022423A1/es not_active Application Discontinuation
- 2000-01-27 SK SK1042-2001A patent/SK10422001A3/sk unknown
- 2000-01-27 AU AU32160/00A patent/AU767039B2/en not_active Ceased
- 2000-01-27 JP JP2000595986A patent/JP2002535392A/ja active Pending
- 2000-01-27 WO PCT/US2000/001991 patent/WO2000044730A1/en not_active Ceased
- 2000-01-27 HU HU0105302A patent/HUP0105302A3/hu unknown
- 2000-01-27 IL IL14416800A patent/IL144168A0/xx unknown
- 2000-01-27 EP EP00909990A patent/EP1147095B1/en not_active Expired - Lifetime
- 2000-01-27 PT PT00909990T patent/PT1147095E/pt unknown
- 2000-01-27 CA CA002356267A patent/CA2356267A1/en not_active Abandoned
- 2000-01-27 EA EA200100809A patent/EA200100809A1/ru unknown
- 2000-01-27 ID IDW00200101465A patent/ID29046A/id unknown
- 2000-01-27 TR TR2001/02131T patent/TR200102131T2/xx unknown
- 2000-01-27 KR KR1020017009430A patent/KR20010101730A/ko not_active Withdrawn
- 2000-01-27 DE DE60012883T patent/DE60012883T2/de not_active Expired - Fee Related
- 2000-01-27 ES ES00909990T patent/ES2223470T3/es not_active Expired - Lifetime
- 2000-01-27 CZ CZ20012637A patent/CZ20012637A3/cs unknown
- 2000-01-27 PL PL00349025A patent/PL349025A1/xx not_active Application Discontinuation
- 2000-01-27 CN CNB008031355A patent/CN1197849C/zh not_active Expired - Fee Related
- 2000-01-27 BR BR0007759-3A patent/BR0007759A/pt not_active IP Right Cessation
- 2000-01-27 NZ NZ511885A patent/NZ511885A/xx unknown
- 2000-01-27 AT AT00909990T patent/ATE273288T1/de not_active IP Right Cessation
2001
- 2001-05-25 ZA ZA200104321A patent/ZA200104321B/en unknown
- 2001-07-26 BG BG105736A patent/BG105736A/xx unknown
- 2001-07-26 NO NO20013675A patent/NO20013675L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ATE273288T1 (de)	2004-08-15
NO20013675D0 (no)	2001-07-26
AR022423A1 (es)	2002-09-04
BR0007759A (pt)	2001-11-13
TR200102131T2 (tr)	2001-12-21
BG105736A (en)	2002-05-31
AU3216000A (en)	2000-08-18
CN1197849C (zh)	2005-04-20
EP1147095A1 (en)	2001-10-24
ZA200104321B (en)	2002-08-26
EA200100809A1 (ru)	2002-02-28
CZ20012637A3 (cs)	2002-04-17
JP2002535392A (ja)	2002-10-22
EP1147095B1 (en)	2004-08-11
HUP0105302A2 (hu)	2002-07-29
SK10422001A3 (sk)	2002-09-10
DE60012883T2 (de)	2005-08-25
CA2356267A1 (en)	2000-08-03
PT1147095E (pt)	2004-12-31
ES2223470T3 (es)	2005-03-01
NZ511885A (en)	2003-06-30
WO2000044730A1 (en)	2000-08-03
AU767039B2 (en)	2003-10-30
HUP0105302A3 (en)	2002-09-30
CN1337952A (zh)	2002-02-27
IL144168A0 (en)	2002-05-23
NO20013675L (no)	2001-09-21
KR20010101730A (ko)	2001-11-14
PL349025A1 (en)	2002-07-01
DE60012883D1 (de)	2004-09-16

Publication	Publication Date	Title
ID29046A (id)	2001-07-26	Asam 2,3,4,5-tetrahidro-1h-(1,4)benzodiazepin-3-hidroksamat sebagai matriks penghambat metaloproteinase
ID26222A (id)	2000-12-07	Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat
ID28699A (id)	2001-06-28	Turunan-turunan asam oksiiminoalkanoat
ID28833A (id)	2001-07-05	Turunan asam 3-aril-2-hidroksipropionat
ID20809A (id)	1999-03-11	Asam diaminokarboksilat tersubstitusi
ID22809A (id)	1999-12-09	Turunan-turunan asam arilsulfonil hidroksamat
ID24376A (id)	2000-07-13	Turunan-turunan asam amidokarboksilat
ATE309220T1 (de)	2005-11-15	Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
ID26379A (id)	2000-12-21	Katalis asam padat
ID28810A (id)	2001-07-05	Senyawa-senyawa amida-omega asam n-arilsulfonilamino
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
ATE369342T1 (de)	2007-08-15	2,5-disubstituierte 3-mercaptopentansaure
DK1164845T3 (da)	2003-09-22	Landbrugskemisk sammensætning
ITTO20000385A0 (it)	2000-04-21	Composizione pesticida.
IT1320765B1 (it)	2003-12-10	Composizione di gomma.
ITBO990671A0 (it)	1999-12-10	Maniglione antipanico.
ITTO20000386A0 (it)	2000-04-21	Composizione pesticida.
IT1311662B1 (it)	2002-03-14	Struttura di calzatura.
ES1044046Y (es)	2000-08-16	Valla.
NL1015547A1 (nl)	2000-09-04	Zeef.
ITTO990195V0 (it)	1999-10-27	Soletta sottopiede.
ES1044233Y (es)	2000-09-01	Calzado convertible.
ES1042496Y (es)	2000-02-01	"pilona sumible".
ES1044367Y (es)	2000-09-01	Piñata mejorada.
DE60017150D1 (de)	2005-02-03	1,4,5,6 -tetrahydropyrimidine-derivative als vitronectin-hemmer